Compare AIP & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIP | CLOV |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.8B |
| IPO Year | 2021 | 2020 |
| Metric | AIP | CLOV |
|---|---|---|
| Price | $29.01 | $4.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $16.83 | $2.90 |
| AVG Volume (30 Days) | 817.3K | ★ 5.2M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 4.65 | ★ 38.03 |
| EPS | N/A | ★ 0.05 |
| Revenue | $70,579,000.00 | ★ $1,924,308,000.00 |
| Revenue This Year | $30.24 | $52.59 |
| Revenue Next Year | $19.50 | $15.37 |
| P/E Ratio | ★ N/A | $85.40 |
| Revenue Growth | 22.27 | ★ 40.34 |
| 52 Week Low | $8.42 | $1.58 |
| 52 Week High | $50.26 | $5.59 |
| Indicator | AIP | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 37.32 | 44.29 |
| Support Level | $13.77 | $1.96 |
| Resistance Level | $38.73 | $4.88 |
| Average True Range (ATR) | 2.23 | 0.25 |
| MACD | -0.47 | -0.08 |
| Stochastic Oscillator | 21.61 | 30.34 |
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum its revenue from Asia Pacific.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.